ResMed Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2022 | $668.7M | $3.28B | $201.8M |
| Jun 2022 | $765.3M | $3.36B | $273.7M |
| Sep 2022 | $785.4M | $3.43B | $207.2M |
| Dec 2022 | $1.79B | $3.74B | $253.2M |
| Mar 2023 | $1.58B | $3.93B | $227.9M |
| Jun 2023 | $1.43B | $4.13B | $227.9M |
| Sep 2023 | $1.35B | $4.25B | $209.1M |
| Dec 2023 | $1.22B | $4.48B | $210.2M |
| Mar 2024 | $997.0M | $4.63B | $237.9M |
| Jun 2024 | $697.3M | $4.86B | $238.4M |
| Sep 2024 | $667.6M | $5.20B | $426.4M |
| Dec 2024 | $662.9M | $5.25B | $521.9M |
| Mar 2025 | $663.1M | $5.55B | $932.7M |
| Jun 2025 | $658.4M | $5.97B | $1.21B |
| Sep 2025 | $408.7M | $6.12B | $1.38B |
| Dec 2025 | $403.9M | $6.32B | $1.42B |
| Mar 2026 | $404.2M | $6.49B | $1.66B |
| Jun 2026 | $399.4M | $6.59B | $1.47B |